• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.初治个体对胆固醇及降脂药物的认知与了解:一项横断面研究
Patient Prefer Adherence. 2025 May 13;19:1411-1422. doi: 10.2147/PPA.S511454. eCollection 2025.
2
Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: the REDISCOVER study.马来西亚人用于心血管疾病一级和二级预防的降脂药物使用的流行情况及相关因素:REDISCOVER 研究。
BMC Public Health. 2022 Feb 4;22(1):228. doi: 10.1186/s12889-022-12595-1.
3
Online Health Information-Seeking in the Era of Large Language Models: Cross-Sectional Web-Based Survey Study.大语言模型时代的在线健康信息搜索:基于网络的横断面调查研究
J Med Internet Res. 2025 Mar 31;27:e68560. doi: 10.2196/68560.
4
Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions.家族性高胆固醇血症患者自我报告的降胆固醇药物依从性:疾病认知的作用。
Cardiovasc Drugs Ther. 2004 Nov;18(6):475-81. doi: 10.1007/s10557-004-6225-z.
5
Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication.开具二线降脂药物的社会人口统计学和诊断特征:依泽替米贝用作初始药物、从他汀类药物转换或联合用药。
Eur J Clin Pharmacol. 2015 Oct;71(10):1245-54. doi: 10.1007/s00228-015-1907-y. Epub 2015 Jul 31.
6
Effectiveness of lipid-lowering medications in outpatients with coronary heart disease in the Department of Veterans Affairs System.
Am J Cardiol. 2003 Nov 15;92(10):1177-82. doi: 10.1016/j.amjcard.2003.07.026.
7
Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.2型糖尿病患者及伴有风险的低密度脂蛋白胆固醇患者的降脂药物处方:一项基于瑞典国家糖尿病登记处的全国性指南依从性研究
BMC Health Serv Res. 2018 Nov 28;18(1):900. doi: 10.1186/s12913-018-3707-4.
8
Impact of lipid-lowering medications and low-density lipoprotein levels on 1-year clinical outcomes after coronary artery bypass grafting.降脂药物和低密度脂蛋白水平对冠状动脉旁路移植术后 1 年临床结局的影响。
J Am Coll Surg. 2013 Sep;217(3):452-60. doi: 10.1016/j.jamcollsurg.2013.04.030. Epub 2013 Jul 25.
9
Attainment of Low-Density Lipoprotein Cholesterol Targets and Prescribing Pattern of Lipid-Lowering Medications among Patients with Familial Hypercholesterolemia Attending Specialist Clinics.家族性高胆固醇血症患者在专科门诊就诊时的低密度脂蛋白胆固醇目标达标情况和降脂药物的处方模式。
J Atheroscler Thromb. 2023 Oct 1;30(10):1317-1326. doi: 10.5551/jat.63389. Epub 2022 Dec 23.
10
Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).血脂控制不理想:来自非干预性俄罗斯中央调查血脂异常治疗不足 II 期研究(CEPHEUS II)的结果。
Cardiovasc Diabetol. 2017 Dec 16;16(1):158. doi: 10.1186/s12933-017-0641-4.

本文引用的文献

1
Cerebrovascular Disease and Statins.脑血管疾病与他汀类药物
Front Cardiovasc Med. 2021 Dec 2;8:778740. doi: 10.3389/fcvm.2021.778740. eCollection 2021.
2
Impact of Adherence, Patient Perception, and Knowledge to Statin Therapy - A Cross-Sectional Study.他汀类药物治疗的依从性、患者认知及知识的影响——一项横断面研究
Indian J Endocrinol Metab. 2021 May-Jun;25(3):206-210. doi: 10.4103/ijem.ijem_120_21. Epub 2021 Oct 26.
3
Statins in a Distorted Mirror of Media.他汀类药物在媒体的扭曲镜像中。
Curr Atheroscler Rep. 2020 Jun 18;22(8):37. doi: 10.1007/s11883-020-00853-9.
4
Evaluation of perceptions, knowledge and compliance with guidelines in real-life practice: A survey on the under-treatment of hypercholesterolemia.现实生活实践中对指南的认知、知识及依从性评估:一项关于高胆固醇血症治疗不足的调查。
Turk Kardiyol Dern Ars. 2019 Oct;47(7):599-608. doi: 10.5543/tkda.2019.39293.
5
The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study.入住心脏病诊所的高龄土耳其患者的心血管疾病患病率、危险因素及心血管药物治疗:ELDER-TURK研究的亚组分析。
Turk Kardiyol Dern Ars. 2018 Jun;46(4):283-295. doi: 10.5543/tkda.2018.49579.
6
[EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey].[欧洲动脉粥样硬化调查-IV:欧洲心脏病学会关于冠状动脉疾病患者生活方式、危险因素及治疗方法的研究:来自土耳其的数据]
Turk Kardiyol Dern Ars. 2017 Mar;45(2):134-144. doi: 10.5543/tkda.2016.82352.
7
Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data.他汀类药物相关媒体报道对他汀类药物使用的影响:基于英国初级医疗数据的中断时间序列分析
BMJ. 2016 Jun 28;353:i3283. doi: 10.1136/bmj.i3283.
8
Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study.负面他汀类药物相关新闻报道降低了他汀类药物的持久性,并增加了心肌梗死和心血管死亡率:一项全国范围的前瞻性队列研究。
Eur Heart J. 2016 Mar 14;37(11):908-916. doi: 10.1093/eurheartj/ehv641. Epub 2015 Dec 1.
9
Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review.了解患者对他汀类药物治疗的看法:我们能否设计出更好的血脂异常管理方法?一项文献综述。
Singapore Med J. 2014 Aug;55(8):416-21. doi: 10.11622/smedj.2014099.
10
An Overview on Coronary Heart Disease (A Comparative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic Strategies.冠心病概述(土耳其与欧洲的比较评估)及诊断策略的成本效益
Mol Imaging Radionucl Ther. 2011 Dec;20(3):75-93. doi: 10.4274/MIRT.33. Epub 2011 Dec 1.

初治个体对胆固醇及降脂药物的认知与了解:一项横断面研究

Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.

作者信息

Kök Mehmet, Bostan Feyzi, Yacan Kök Ayşe

机构信息

Department of Internal Medicine, Antalya Training and Research Hospital of Ministry of Health, Antalya, Turkey.

Bucak Health School, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.

出版信息

Patient Prefer Adherence. 2025 May 13;19:1411-1422. doi: 10.2147/PPA.S511454. eCollection 2025.

DOI:10.2147/PPA.S511454
PMID:40386799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12085121/
Abstract

PURPOSE

The literature often includes studies on cholesterol perception and lipid-lowering medication (LLM) use with patients who have used or discontinued LLM for primary or secondary prevention. With the exponential rise in patients needing LLM each year, understanding their knowledge and perceptions of cholesterol and these drugs is crucial. For this reasons, we aimed to determine the perception and knowledge of treatment-naive participants about cholesterol and LLM.

PATIENTS AND METHODS

This cross-sectional study was conducted in Turkey between August 2020 and August 2022. A self-designed online survey developed from literature sources was used to determine the level of knowledge and perception of cholesterol, LLM and influencing factors.

RESULTS

A total of 2062 respondents completed the survey, which was sent to the participants via an online link. The most common sources of information about cholesterol and lipid-lowering medications were medical staff (71%) media (58.4%) and scientific publications (33.3%). The most three common factors affecting the participants' perception of cholesterol and LLM were medical staff (49.6%), media (23.7%), and scientific publications (15.6%).

CONCLUSION

Our study revealed that participants have some inaccurate and incomplete information about cholesterol and LLM. Medical staff and the media emerged as the primary sources of information and crucial influences on most participants' perceptions of cholesterol and LLM.

摘要

目的

文献中经常包含对已使用或停用降脂药物(LLM)进行一级或二级预防的患者的胆固醇认知和降脂药物使用情况的研究。随着每年需要使用降脂药物的患者数量呈指数级增长,了解他们对胆固醇和这些药物的知识及认知至关重要。出于这个原因,我们旨在确定初治参与者对胆固醇和降脂药物的认知和知识水平。

患者与方法

这项横断面研究于2020年8月至2022年8月在土耳其进行。采用从文献来源开发的自行设计的在线调查问卷,以确定对胆固醇、降脂药物及其影响因素的知识和认知水平。

结果

共有2062名受访者完成了通过在线链接发送给参与者的调查问卷。关于胆固醇和降脂药物最常见的信息来源是医务人员(71%)、媒体(58.4%)和科学出版物(33.3%)。影响参与者对胆固醇和降脂药物认知的最常见的三个因素是医务人员(49.6%)、媒体(23.7%)和科学出版物(15.6%)。

结论

我们的研究表明,参与者对胆固醇和降脂药物有一些不准确和不完整的信息。医务人员和媒体成为主要的信息来源,并对大多数参与者对胆固醇和降脂药物的认知产生关键影响。